Related Experiment Video
Updated: Jul 7, 2026

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
Published on: November 2, 2014
Molecular imaging in oncology
1GlaxoSmithKline, 891-995 Greenford Road, Middlesex, UB6 0HE, UK.
Abstract:
Cancer is a genetic disease that manifests in loss of normal cellular homeostatic mechanisms. The biology and therapeutic modulation of neoplasia occurs at the molecular level. An understanding of these molecular processes is therefore required to develop novel prognostic and early biomarkers of response. In addition to clinical applications, increased impetus for the development of such technologies has been catalysed by pharmaceutical companies investing in the development of molecular therapies. The discipline of molecular imaging therefore aims to image these important molecular processes in vivo. Molecular processes, however, operate at short length scales and concentrations typically beyond the resolution of clinical imaging. Solving these issues will be a challenge to imaging research. The successful implementations of molecular imaging in man will only be realised by the close co-operation amongst molecular biologists, chemists and the imaging scientists.
Insights
Molecular imaging aims to visualize cancer's molecular processes in vivo. Overcoming resolution limits requires collaboration between biologists, chemists, and imaging scientists for clinical success.
Area of Science:
- Oncology
- Molecular Biology
- Medical Imaging
Background:
- Cancer is a genetic disease involving the loss of cellular homeostasis.
- Understanding molecular processes is key for developing cancer biomarkers and therapies.
- Pharmaceutical investment drives the need for molecularly targeted treatments.
Purpose of the Study:
- To highlight the role of molecular imaging in visualizing cancer's molecular underpinnings.
- To identify challenges and requirements for advancing in vivo molecular imaging.
- To emphasize the necessity of interdisciplinary collaboration for clinical translation.
Main Methods:
- The abstract discusses the conceptual framework and challenges of molecular imaging.
- It emphasizes the need for understanding molecular processes at the cellular level.
- It highlights the limitations of current clinical imaging resolution for molecular targets.
Main Results:
- Molecular processes in cancer occur at scales and concentrations challenging for current imaging.
- Significant advancements are needed to bridge the gap between molecular events and imaging capabilities.
- Interdisciplinary collaboration is crucial for overcoming these technical hurdles.
Conclusions:
- Molecular imaging holds promise for understanding and treating cancer at its source.
- Successful clinical implementation hinges on integrating expertise from molecular biology, chemistry, and imaging science.
- Addressing resolution and sensitivity limitations is paramount for future molecular imaging applications in oncology.
More Related Videos
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
06:54MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013